Quest Diagnostics, Inc. (NYSE:DGX)
CAPS Rating:
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
RSS Headlines
Fool UK
Recs
Price/Share - 1.4Price/Earnings - 15Price/Book - 2.6Over the last 10 years or so Quest has never traded below these multipliers. So if Quest Diagnostics performance on par with S&P500 and there is just a slight multiple expansion towards the more typical than Quest will probably be outperforming the Price of S&P.